4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001415889-22-004098
Options or other derivatives
- CEO acquired 170,989 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| MULLEN JAMES C CEO | 2022-04-14 | Grant or award · Stock Option (right to buy) | +170,989 | 170,989 | D | ||
Loading xslF345X03/form4-04182022_040401.xml…